Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Rheumatoid Arthritis
NCT00095498Phase 2Completed
- Sponsor
- Amgen
- Start
- Aug 2004
- Primary completion
- Apr 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of denosumab in rheumatoid arthritis (RA), sponsored by Amgen. Started Aug 2004; status: completed.
02
Drugs
denosumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00095498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095498.